C4 Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Core Insights - C4 Therapeutics, Inc. (C4T) is a clinical-stage biopharmaceutical company focused on advancing targeted protein degradation science [1][3] - The company will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 [1] - C4T utilizes its TORPEDO platform to design small-molecule medicines that target disease-causing proteins, aiming to improve patient outcomes and address drug resistance [3] Company Overview - C4 Therapeutics is dedicated to creating a new generation of medicines that transform patients' lives through targeted protein degradation [3] - The company is advancing multiple targeted oncology programs and expanding its research platform for difficult-to-treat diseases [3] - C4T's approach leverages the body's natural protein recycling system to rapidly degrade harmful proteins [3]